The most valued event at the Aseptic Conference is always the regulatory panel. Every year we give a long list of questions to the panelists to discern the fine lines of good aseptic design, implementation, and operation. That is one great reason why this discussion panel, more than any other, allows our industry to understand and plan for best practices.
One of the significant challenges our industry currently faces is finding and/or training qualified staff. The Aseptic Conference is full of detailed technical content that allows quality, engineering, safety, and operations staff to learn about the science behind the applied technology. All this information ensures that the “why” behind the “what” is also understood. Technical know-how and growth at the facility level are critical for they allow for more effective and efficient operations. Many would-be observations can be avoided with well-documented risk assessments while supporting technical topics with sound scientific research.
Excludes current registrants. $400 Off In-Person/$250 Off Virtual only valid until 31 December 2021 for full industry member and nonmember rates only.
Our 2022 Aseptic Conference will have topics ranging from ATMP production facility planning (this is a discussion group with some of the most well-known industry facility planners) to new technologies in biodecontamination cycles. We have included tracks focusing on novel aspects of robotics, understanding the containment aspects of highly active hazardous compounds, and one of the hottest topics, the soon to be updated Annex 1, Contamination Control Strategy.
For a good reason, aseptic operations are at the heart of all pharmaceutical operations the regulatory agencies scrutinize. They are the last point in the process where the active medicine molecules are handled just prior to delivery to the patient. If something is not performed correctly, it could result in an effect on the patient. All these topics, discussed by our colleagues, demonstrate how essential protecting the patient is to our industry.
The people that work in aseptic operations are some of the unsung heroes of the COVID-19 recovery. The vaccine production, and manufacturing of many other Parenteral products, are the key to preventing and treating COVID-19. These products contribute to our fight against other illnesses, too. Without them, we could not return to society with preventative or treatments.
What I enjoy in our Aseptic Conference is the desire to look further. Not only will we be looking at what we have learned. We will be pushing for the details of what we will be working on next. What will be the next innovation that changes the way we do business? What can we expect? Because...how else will manufacturing evolve?
I’m particularly excited that ISPE’s Women in Pharma will host a breakfast discussion again. Some of our trusted members will present recent survey results regarding fill line capacity increases in the industry during this session.
Yes, indeed. We are already planning for the future.